Forefront Analytics
WEST CONSHOHOCKEN, PAfiles as Forefront Analytics, LLC
$92m in 37 US stocks at the end of 30 June 2026. The top 10 are 82.7% of the money. It changed about 17.8% of the portfolio this quarter.
Value
$92m
Stocks
37
Top 10 share
82.7%
Turnover
17.8%
What changed this quarter
New
Bought for the first time this quarter.
None this quarter.
Added
Bought more of a stock they already held.
- NvidiaNVDA4.2% of the fund+37%
- DeereDE0.8% of the fund+3%
- IncyteINCY0.6% of the fund+20%
- Abbott LaboratoriesABT0.6% of the fund+12%
- PfizerPFE0.5% of the fund+39%
- DanaherDHR0.4% of the fund+58%
- Thermo Fisher ScientificTMO0.4% of the fund+16%
- Zura BioZURA0.2% of the fund+81%
- GeronGERN0.1% of the fund+61%
- CytomX TherapeuticsCTMX0.1% of the fund+101%
- Bicycle TherapeuticsBCYC0.1% of the fund+52%
Cut
Sold some of their stake.
- Ishares TRESGD11.6% of the fund-59%
- IsharesESGE11.4% of the fund-48%
- Nushares ETF TRNULV7.7% of the fund-28%
- Flexshares TRESGG5.5% of the fund-51%
- UnitedHealth GroupUNH0.6% of the fund-29%
- Edwards LifesciencesEW0.6% of the fund-6%
- Wisdomtree TREES0.5% of the fund-15%
- Legend BiotechLEGN0.3% of the fund-33%
- Regeneron PharmaceuticalsREGN0.3% of the fund-10%
- Schwab Strategic TRSCHD0.3% of the fund-49%
- Vanguard Index FDSVTV0.3% of the fund-18%
- NkartaNKTX<0.1% of the fund-34%
Sold out
Sold their entire stake.
- Dimensional ETF TrustDFSV-100%
- Mereo Biopharma GroupMREO-100%
Holdings
- Vanguard Intl Equity Index FVWO
- Share
- 11.7%
- Value
- $11m
- Shares
- 180,376
Held
- Ishares TRESGD
- Share
- 11.6%
- Value
- $11m
- Shares
- 104,247
-59%
- IsharesESGE
- Share
- 11.4%
- Value
- $11m
- Shares
- 192,398
-48%
- Ishares TRHDV
- Share
- 10.2%
- Value
- $9m
- Shares
- 342,756
Held
- Ishares TRMTUM
- Share
- 9.1%
- Value
- $8m
- Shares
- 24,434
Held
- Nushares ETF TRNULV
- Share
- 7.7%
- Value
- $7m
- Shares
- 140,912
-28%
- DBX ETF TRDBEF
- Share
- 7.5%
- Value
- $7m
- Shares
- 126,734
Held
- Flexshares TRESGG
- Share
- 5.5%
- Value
- $5m
- Shares
- 21,669
-51%
- Vanguard Tax-Managed FDSVEA
- Share
- 3.7%
- Value
- $3m
- Shares
- 47,559
Held
- Ishares TRIVV
- Share
- 3.6%
- Value
- $3m
- Shares
- 4,450
Held
- IsharesHEEM
- Share
- 2.8%
- Value
- $3m
- Shares
- 58,203
Held
- Proshares TRSSO
- Share
- 0.6%
- Value
- $551,159
- Shares
- 8,180
Held
- Proshares TRUWM
- Share
- 0.6%
- Value
- $537,666
- Shares
- 7,997
Held
- Wisdomtree TREES
- Share
- 0.5%
- Value
- $475,886
- Shares
- 7,020
-15%
- Legend BiotechLEGN
- Share
- 0.3%
- Value
- $305,204
- Shares
- 10,568
-33%
- Schwab Strategic TRSCHD
- Share
- 0.3%
- Value
- $243,406
- Shares
- 7,676
-49%
- Vanguard Index FDSVTV
- Share
- 0.3%
- Value
- $236,319
- Shares
- 1,084
-18%
- Bicycle TherapeuticsBCYC
- Share
- 0.1%
- Value
- $92,525
- Shares
- 21,822
+52%
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| Vanguard Intl Equity Index FVWO | 11.7% | $11m | 180,376 | Held |
| Ishares TRESGD | 11.6% | $11m | 104,247 | -59% |
| IsharesESGE | 11.4% | $11m | 192,398 | -48% |
| Ishares TRHDV | 10.2% | $9m | 342,756 | Held |
| Ishares TRMTUM | 9.1% | $8m | 24,434 | Held |
| Nushares ETF TRNULV | 7.7% | $7m | 140,912 | -28% |
| DBX ETF TRDBEF | 7.5% | $7m | 126,734 | Held |
| Flexshares TRESGG | 5.5% | $5m | 21,669 | -51% |
| NvidiaNVDA | 4.2% | $4m | 19,532 | +37% |
| Vanguard Tax-Managed FDSVEA | 3.7% | $3m | 47,559 | Held |
| Ishares TRIVV | 3.6% | $3m | 4,450 | Held |
| IsharesHEEM | 2.8% | $3m | 58,203 | Held |
| JPMorgan ChaseJPM | 1.8% | $2m | 4,997 | Held |
| DeereDE | 0.8% | $743,196 | 1,172 | +3% |
| UnitedHealth GroupUNH | 0.6% | $585,796 | 1,409 | -29% |
| IncyteINCY | 0.6% | $577,116 | 5,091 | +20% |
| Edwards LifesciencesEW | 0.6% | $557,053 | 6,158 | -6% |
| Proshares TRSSO | 0.6% | $551,159 | 8,180 | Held |
| Proshares TRUWM | 0.6% | $537,666 | 7,997 | Held |
| Abbott LaboratoriesABT | 0.6% | $514,078 | 5,665 | +12% |
| Wisdomtree TREES | 0.5% | $475,886 | 7,020 | -15% |
| PfizerPFE | 0.5% | $438,489 | 18,210 | +39% |
| MedtronicMDT | 0.5% | $416,108 | 5,319 | Held |
| DanaherDHR | 0.4% | $388,506 | 2,040 | +58% |
| Thermo Fisher ScientificTMO | 0.4% | $335,619 | 669 | +16% |
| Blue Owl Technology FinanceOTF | 0.3% | $306,919 | 29,654 | Held |
| Legend BiotechLEGN | 0.3% | $305,204 | 10,568 | -33% |
| Philip Morris InternationalPM | 0.3% | $264,600 | 1,463 | Held |
| Regeneron PharmaceuticalsREGN | 0.3% | $258,830 | 415 | -10% |
| Schwab Strategic TRSCHD | 0.3% | $243,406 | 7,676 | -49% |
| Vanguard Index FDSVTV | 0.3% | $236,319 | 1,084 | -18% |
| Zura BioZURA | 0.2% | $159,111 | 26,968 | +81% |
| GeronGERN | 0.1% | $113,637 | 88,779 | +61% |
| CytomX TherapeuticsCTMX | 0.1% | $93,874 | 25,033 | +101% |
| Bicycle TherapeuticsBCYC | 0.1% | $92,525 | 21,822 | +52% |
| NkartaNKTX | <0.1% | $81,943 | 28,955 | -34% |
| AnnexonANNX | <0.1% | $81,310 | 14,240 | Held |
Over time and by industry
Value over time
Jun '25
Dec '25
Jun '26
Value is up 2.8% since 30 June 2025.
Where the money is
Health care5.0%
Technology4.2%
Financial services1.8%
Industrials0.8%
Everyday goods0.3%
Other87.9%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.